Rezolute, Inc.
NASDAQ:RZLTBiotechnology
Healthcare
$4.20 +6.16%
+$0.30 today
- Market cap
- $406.26M
- Beta
- 0.65
- P/E (TTM)
- -6.5
- EPS (TTM)
- -$0.78
52W Low $1.07High $11.46
Volume 2.37M
Average 2.03M
Balance Sheet
Inspect the capital base behind the business.
Assets
$175.49M
FY 2025 · Annual
+32.2% YoYLiabilities
$13.36M
FY 2025 · Annual
+13.9% YoYEquity
$162.13M
FY 2025 · Annual
+34.0% YoYBalance Sheet
USD
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 41.05M | 150.41M | 16.04M | 70.4M | 94.11M |
| Short-term Investments | 0 | 0 | 85.86M | 56.48M | 73.75M |
| Net Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 1.78M | 3.29M |
| Total Current Assets | 41.99M | 152.1M | 104.91M | 128.65M | 171.15M |
| Property, Plant & Equipment (Net) | 425K | 168K | 2.19M | 1.98M | 1.42M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 16.47M | 263K | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 191K | 148K | 148K | 1.84M | 2.93M |
| Total Non-current Assets | 616K | 316K | 18.81M | 4.08M | 4.35M |
| Total Assets | 42.61M | 152.42M | 123.72M | 132.74M | 175.49M |
| Account Payables | 1.04M | 1.13M | 3.27M | 4.9M | 5.81M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 77K | 0 | 883K | 1.81M | 2.27M |
| Total Current Liabilities | 1.97M | 2.46M | 5.2M | 9.61M | 11.91M |
| Long-term Debt | 13.97M | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 387K | 407K | 412K | 468K | 468K |
| Total Non-current Liabilities | 14.54M | 487K | 2.35M | 2.13M | 1.45M |
| Total Liabilities | 16.51M | 2.95M | 7.55M | 11.73M | 13.36M |
| Common Stock | 8K | 34K | 37K | 53K | 87K |
| Retained Earnings | (168.14M) | (209.2M) | (260.99M) | (329.44M) | (403.86M) |
| Accumulated OCI | 0 | 0 | (351K) | (79K) | (7K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 26.1M | 149.47M | 116.17M | 121M | 162.13M |
| Total Debt | 14.42M | 188K | 2.48M | 2.23M | 1.62M |
| Net Debt | (26.63M) | (150.22M) | (13.56M) | (68.17M) | (92.49M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $11.2M |
| Short-term Investments | $109.0M |
| Receivables | $600.0K |
| Other Current | $1.2M |
| Total Current Assets | $122.0M |
| PP&E (Net) | $967.0K |
| Other Non-current | $2.4M |
| Total Non-current Assets | $3.4M |
| Total Assets | $125.5M |
Analysis
Selected assets total $125.5M for Latest. The largest visible component is Short-term Investments at $109.0M, about 86.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| FWP | FWP filing | Nov 13, 2026 | |
| SC 13G/A | SC 13G/A filing | Nov 13, 2026 | |
| 424B5 | 424B5 filing | Nov 13, 2026 | |
| SC 13G | SC 13G filing | Nov 13, 2026 | |
| 8-K | Current report | Nov 13, 2026 |
How much cash does RZLT have?
Rezolute, Inc. (RZLT) reported $94.11M in cash and equivalents in fiscal 2025.
How much debt does RZLT carry?
Rezolute, Inc. (RZLT) reported $1.61M of total debt, with net debt of -$92.49M.
Continue the stock analysis
Jump to another research area for this company.